OECD CRITICISES WEAK IMPLEMENTATION OF ANTI-COUNTERFEITING LAWS

BY KEITH NUTHALL THE ORGANISATION for Economic Cooperation and Development (OECD) has criticised weak implementation of anti-counterfeiting laws in countries that are a major source of fake medicines. In its report the Economic Impact of Counterfeiting and Piracy, the OECD noted that Brazil, China, India, and Russia, all have trademark laws with civil and criminal remedies against pharmaceutical counterfeiting, including "graduated levels of fines and terms of imprisonment". However, "while the remedies may be available [there is widespread] ...


Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.